New

Venous Stents Market

2021

Venous Stents Market to 2025 - Global Analysis and Forecasts by Technology (Wallstent Technology and Iliac Vein Stent Technology); Application (Legs, Chest and Abdomen); Disease (Post Thrombotic Syndrome, Chronic Deep Vein Thrombosis, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Others); and Geography

Publication Month: Nov 2018 | Report Code: TIPMD00002388 | No. of Pages: 115 | Category: Medical Device | Status: Published

Market Insights

Venous Stents Market to Grow at a CAGR of 9.7% to reach US$ 1,727.4 Mn from 2017 to 2025

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The Venous stents in healthcare market was valued at US$ 829.0 million in 2017 and it is projected to reach US$ 1,727.4 million by 2025; it is expected to grow at a CAGR of 9.7% from 2018 to 2025.

The venous stents are mesh tubes made up metal that expands against the blocked veins or the narrowed veins. These stents play role of a scaffold that assist in keeping the walls of veins open. The venous stents are generally placed in the central veins which are found in legs, chest and abdomen. The venous stents are used to treat conditions such as chronic deep vein thrombosis (DVT), post thrombotic syndrome and more. The growth of the Venous stents in healthcare market is attributed to the rising venous diseases, technological advancements in stent technology and rising geriatric populations are key drivers for the growth of the market. However, the growth of the market is restrained by various factors such as stringent regulations for approval and high cost of surgical procedures.

The Venous stents in healthcare market is expected to witness substantial growth post-pandemic. The Venous stents in healthcare market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.

Lucrative Regions for Venous stents in Healthcare Market
Lucrative Regions for Venous stents in Healthcare Market

Get more information on this report :



Market Insights

Growing Applications of Venous stents in Healthcare to Drive Venous stents in Healthcare Market Growth

Conditions that damage the veins are termed as venous diseases. Common venous disorders include: venous thrombosis, deep vein thrombosis, venous stasis, venous ulcers, arteriovenous fistula, post-thrombotic syndrome, thrombophlebitis and others. According to the Johns Hopkins University around 15% of the US population suffers from varicose veins. Also, according to the Centers for Disease Control and Prevention, every year approximately 900,000 (1 - 2 per 1,000) people are affected by deep vein thrombosis (DVT) in the United States. It also mentioned that 33% of people with DVT will have recurrence of DVT within 10 years. Furthermore, thrombophilia is the condition wherein predisposition leads to formation of clots. The predisposition to form clots can arise from genetic factors, genetic thrombophilia results when there is deficiency in inherited factor, such as antithrombin or protein C. The Centers for Disease Control and Prevention estimated that 5-8% people in the US have inherited thrombophilias.

Owing to the rising cases of venous diseases in the regions and in various countries, the need and demand for the venous stents for the treatment of the venous disorders increases, thus enhancing the market growth in the future years.

Advancement in the field of stent technology has equally enhanced the market for venous stents. Many industry players have come up with innovative types of venous stents in last few years. The defects and technical shortcomings for performing venous stenting procedures have led to a revolution of the newer nitinol stents. For instance, in January 2018, Medtronic plc. broadcasted an initiation of its investigational device exemption (IDE) study for the Abre, its venous self-expanding stent system. The new abre stent is developed for permanent implant in the iliofemoral vein. Upon placement of the Abre stent, the stent offers optimized balance of strength and flexibility to exert an outward force and open the vein. Similarly, in November 2016, Cook Medical announced the initiation of VIVO clinical study that assesses the safety and effectiveness of the Zilver Vena venous stent that is used for the treatment of symptomatic iliofemoral venous outflow obstruction. Thus, many companies are growing their venous product portfolio to offer a comprehensive portfolio for the treatment of venous diseases.

Advancement in venous stents has made the treatment of venous diseases easy and accurate. These technological advancements are likely to grow the market in near future.

Incidence rates for deep venous thrombosis (DVT) and pulmonary embolism (PE) increases with increasing age in both men and women. This is due to age related alterations in thrombotic factors and laxity in large venous valves. According to the NHS foundation, 90-95% of deep venous thrombosis or pulmonary embolism cases are in people aged over 40 years. Furthermore, chronic diseases like cancer, surgeries or immobilization, transvenous pacemaker, central venous catheters, infection, kidney disease, thrombophilia, and leg paresis from neurological disease are more prevalent in aged population and all these diseases are independent predictors of venous thromboembolism events.

Globally the geriatric population is increasing, every country is experiencing the rise in older population. According to the United Nations data from World Population Prospects 2017, 962 million people are aged 60 or over in the world and is expected to reach 2.1 billion by 2050 and 3.1 billion by 2100. It also mentioned that Europe is having the largest share of old aged population about 25%. Thus, the growing geriatric population, increases the applications of venous stents and eventually favors market growth.

Technology-Based Insights

In terms of technology, the Venous stents in healthcare market is segmented into wallstent technology and iliac vein stent technology. In 2017, the iliac vein stent technology segment held a largest market share of 73.9% of the venous stents, by technology.

Venous stents in Healthcare Market, by Technology – 2017 and 2025
Venous stents in Healthcare Market, by Technology – 2017 and 2025

Get more information on this report :



Application-Based Insights

Based on application, the Venous stents in healthcare market is segmented into legs, chest, and abdomen. The leg segment is anticipated to grow at a CAGR of 9.6% during the forecast period. The growth of leg segment is primarily driven due to increasing number of the incidences for the deep vein thrombosis in the geriatric population.

Disease-Based Insights

In terms of disease, the Venous stents in healthcare market is segmented into post thrombotic syndrome, chronic deep vein thrombosis, may-thurner syndrome, hemodialysis/arteriovenous fistulae and others. In 2017, the chronic deep vein thrombosis segment held a largest market share of 30.4% of the venous stents, by disease.

Strategic Insights

The Venous stents in healthcare market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

Venous stents in Healthcare Market – by Technology

  • Wallstent Technology,
  • Iliac Vein Stent Technology

Venous stents in Healthcare Market – by Application

  • Legs
  • Chest
  • Abdomen

Venous stents in Healthcare Market – by Disease

  • Post Thrombotic Syndrome,
  • Chronic Deep Vein Thrombosis,
  • May-Thurner Syndrome,
  • Hemodialysis/Arteriovenous Fistulae, and
  • Others

Venous stents in Healthcare Market – by Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East & Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South America and Central America (SCAM)

    • Brazil
    • Argentina
    • Rest of SCAM

Company Profiles

  • Boston Scientific Corporation
  • C. R Bard (acquired by BD)
  • Jotech GMBH (acquired by Cryolife, Inc.)
  • Cook
  • W.L Gore & Associates
  • Optimed Medizinische Instrumente GMBH
  • Medtronic
  • Medica Germany GMBH & Co. KG
  • Cordis
TABLE OF CONTENTS

1. INTRODUCTION 19
1.1 SCOPE OF THE STUDY 19
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 19

2. GLOBAL VENOUS STENTS MARKET – KEY TAKEAWAYS 20

3. GLOBAL VENOUS STENTS MARKET – MARKET LANDSCAPE 23
3.1 OVERVIEW 23
3.2 MARKET SEGMENTATION 23
3.2.1 Global Venous stents Market – By Product 24
3.2.2 Global Venous stents Market – By Application 24
3.2.3 Global Venous stents Market – By Disease 25
3.2.4 Global Venous stents Market – By Geography 25

4. GLOBAL VENOUS STENTS MARKET – KEY MARKET DYNAMICS 26
4.1 KEY MARKET DRIVERS 26
4.1.1 Rising Prevalence of Venous Diseases 26
4.1.2 Technological Advancements in Stent Technology 26
4.1.3 Rising Global Geriatric Population 27
4.2 KEY MARKET RESTRAINTS 27
4.2.1 Stringent Regulations For Approval 27
4.2.2 High Cost Of Surgical Procedures 27
4.3 KEY MARKET OPPORTUNITIES 28
4.3.1 Emerging Markets 28
4.4 FUTURE TRENDS 28
4.4.1 Development of Advanced Venous Stents 28
4.5 IMPACT ANALYSIS 29

5. VENOUS STENTS MARKET – GLOBAL ANALYSIS 30
5.1 GLOBAL VENOUS STENTS REVENUE FORECASTS AND ANALYSIS 30
5.2 GLOBAL VENOUS STENTS, BY GEOGRAPHY - FORECASTS AND ANALYSIS 31
5.3 PERFORMANCE OF KEY PLAYERS 32
5.3.1 Boston Scientific Corporation 32
5.3.2 C. R. Bard, Inc. 32
5.4 EXPERT OPINIONS 33

6. GLOBAL VENOUS STENTS MARKET ANALYSIS– BY TECHNOLOGY 34
6.1 OVERVIEW 34
6.2 WALLSTENT TECHNOLOGY 35
6.2.1 Overview 35
6.2.2 Global Wallstent Technology Market Revenue and Forecasts to 2025 (US$ Mn) 35
6.3 ILIAC VEIN STENT TECHNOLOGY 36
6.3.1 Overview 36
6.3.2 Global Iliac Vein Stent Technology Market Revenue and Forecasts to 2025 (US$ Mn) 36

7. GLOBAL VENOUS STENTS MARKET ANALYSIS– BY APPLICATION 37
7.1 OVERVIEW 37
7.2 LEGS MARKET 38
7.2.1 Overview 38
7.2.2 Global Legs Market Revenue and Forecasts to 2025 (US$ Mn) 38
7.3 CHEST MARKET 39
7.3.1 Overview 39
7.3.2 Global Chest Market Revenue and Forecasts to 2025 (US$ Mn) 39
7.4 ABDOMEN MARKET 40
7.4.1 Overview 40
7.4.2 Global Abdomen Market Revenue and Forecasts to 2025 (US$ Mn) 40

8. GLOBAL VENOUS STENTS MARKET ANALYSIS– BY DISEASES 41
8.1 OVERVIEW 41
8.2 POST THROMBOTIC SYNDROME MARKET 42
8.2.1 Overview 42
8.2.2 Global Post Thrombotic Syndrome Market Revenue and Forecasts to 2025 (US$ Mn) 42
8.3 CHRONIC DEEP VEIN THROMBOSIS 43
8.3.1 Overview 43
8.3.2 Global Chronic Deep Vein Thrombosis Market Revenue and Forecasts to 2025 (US$ Mn) 43
8.4 MAY-THURNER SYNDROME 44
8.4.1 Overview 44
8.4.2 Global May-Thurner Syndrome Market Revenue and Forecasts to 2025 (US$ Mn) 44
8.5 HEMODIALYSIS/ARTERIOVENOUS FISTULAE 45
8.5.1 Overview 45
8.5.2 Global Hemodialysis/Arteriovenous Fistulae Market Revenue and Forecasts to 2025 (US$ Mn) 45
8.6 OTHERS 46
8.6.1 Overview 46
8.6.2 Global Others Market Revenue and Forecasts to 2025 (US$ Mn) 46

9. NORTH AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 47
9.1 OVERVIEW 47
9.2 NORTH AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 48
9.3 NORTH AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 48
9.4 NORTH AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 49
9.5 NORTH AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 49
9.6 NORTH AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY, (2017 & 2025) (%) 50
9.7 US VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 50
9.7.1 US Venous Stents Market Revenue and Forecasts to 2025 (US$ Mn) 51
9.7.2 US Venous Stents Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 51
9.7.3 US Venous Stents Market Revenue And Forecasts to 2025, By Application (US$ Mn) 52
9.7.4 US Venous Stents Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 52
9.8 CANADA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 53
9.8.1 Canada Venous Stents Market Revenue and Forecasts to 2025 (US$ Mn) 53
9.8.2 Canada Venous Stents Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 54
9.8.3 Canada Venous Stents Market Revenue And Forecasts to 2025, By Application (US$ Mn) 54
9.8.4 Canada Venous Stents Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 54
9.9 MEXICO VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 55
9.9.1 Mexico Venous Stents Market Revenue and Forecasts to 2025 (US$ Mn) 55
9.9.2 Mexico Venous Stents Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 56
9.9.3 Mexico Venous Stents Market Revenue And Forecasts to 2025, By Application (US$ Mn) 56
9.9.4 Mexico Venous Stents Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 56

10. EUROPE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 57
10.1 OVERVIEW 57
10.2 EUROPE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 58
10.3 EUROPE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 58
10.4 EUROPE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 59
10.5 EUROPE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 59
10.6 EUROPE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY, (2017 & 2025) (%) 60
10.7 GERMANY VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 61
10.7.1 Germany Venous Stents Market Revenue and Forecasts to 2025 (US$ Mn) 61
10.7.2 Germany Venous Stents Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 62
10.7.3 Germany Venous Stents Market Revenue And Forecasts to 2025, By Application (US$ Mn) 62
10.7.4 Germany Venous Stents Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 62
10.8 UK VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 63
10.8.1 UK Venous Stents Market Revenue and Forecasts to 2025 (US$ Mn) 63
10.8.2 UK Venous Stents Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 64
10.8.3 UK Venous Stents Market Revenue And Forecasts to 2025, By Application (US$ Mn) 64
10.8.4 UK Venous Stents Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 64
10.9 FRANCE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 65
10.9.1 France Venous Stents Market Revenue and Forecasts to 2025 (US$ Mn) 65
10.9.2 France Venous Stents Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 66
10.9.3 France Venous Stents Market Revenue And Forecasts to 2025, By Application (US$ Mn) 66
10.9.4 France Venous Stents Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 66

11. ASIA-PACIFIC VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 67
11.1 OVERVIEW 67
11.2 ASIA PACIFIC VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 68
11.3 ASIA PACIFIC VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 68
11.4 ASIA PACIFIC VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 69
11.5 ASIA PACIFIC VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 69
11.6 ASIA PACIFIC VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY, (2017 & 2025) (%) 70
11.7 CHINA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70
11.7.1 China Venous Stents Market Revenue and Forecasts to 2025 (US$ Mn) 71
11.7.2 China Venous Stents Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 71
11.7.3 China Venous Stents Market Revenue And Forecasts to 2025, By Application (US$ Mn) 72
11.7.4 China Venous Stents Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 72
11.8 JAPAN VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 73
11.8.1 Japan Venous Stents Market Revenue and Forecasts to 2025 (US$ Mn) 73
11.8.2 Japan Venous Stents Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 74
11.8.3 Japan Venous Stents Market Revenue And Forecasts to 2025, By Application (US$ Mn) 74
11.8.4 Japan Venous Stents Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 74
11.9 INDIA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 75
11.9.1 India Venous Stents Market Revenue and Forecasts to 2025 (US$ Mn) 75
11.9.2 India Venous Stents Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 76
11.9.3 India Venous Stents Market Revenue And Forecasts to 2025, By Application (US$ Mn) 76
11.9.4 India Venous Stents Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 76

12. MIDDLE EAST & AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 77
12.1 OVERVIEW 77
12.2 MIDDLE EAST & AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 78
12.3 MIDDLE EAST & AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 78
12.4 MIDDLE EAST & AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 79
12.5 MIDDLE EAST & AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 79
12.6 MIDDLE EAST & AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY, (2017 & 2025) (%) 80
12.7 U.A.E. VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 81
12.7.1 U.A.E. Venous Stents Market Revenue and Forecasts to 2025 (US$ Mn) 81
12.7.2 U.A.E. Venous Stents Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 82
12.7.3 U.A.E. Venous Stents Market Revenue And Forecasts to 2025, By Application (US$ Mn) 82
12.7.4 U.A.E. Venous Stents Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 82
12.8 SAUDI ARABIA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 83
12.8.1 Saudi Arabia Venous Stents Market Revenue and Forecasts to 2025 (US$ Mn) 83
12.8.2 Saudi Arabia Venous Stents Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 84
12.8.3 Saudi Arabia Venous Stents Market Revenue And Forecasts to 2025, By Application (US$ Mn) 84
12.8.4 Saudi Arabia Venous Stents Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 84
12.9 SOUTH AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 85
12.9.1 South Africa Venous Stents Market Revenue and Forecasts to 2025 (US$ Mn) 85
12.9.2 South Africa Venous Stents Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 86
12.9.3 South Africa Venous Stents Market Revenue And Forecasts to 2025, By Application (US$ Mn) 86
12.9.4 South Africa Venous Stents Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 86

13. SOUTH AND CENTRAL AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 87
13.1 OVERVIEW 87
13.2 SOUTH AND CENTRAL AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 88
13.3 SOUTH AND CENTRAL AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 88
13.4 SOUTH AND CENTRAL AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 89
13.5 SOUTH AND CENTRAL AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 89
13.6 SOUTH & CENTRAL AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY, (2017 & 2025) (%) 90
13.7 BRAZIL VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 91
13.7.1 Brazil Venous Stents Market Revenue and Forecasts to 2025 (US$ Mn) 91
13.7.2 Brazil Venous Stents Market Revenue And Forecasts to 2025, By Technology (US$ Mn) 92
13.7.3 Brazil Venous Stents Market Revenue And Forecasts to 2025, By Application (US$ Mn) 92
13.7.4 Brazil Venous Stents Market Revenue And Forecasts to 2025, By Disease (US$ Mn) 92

14. VENOUS STENTS MARKET –KEY COMPANY PROFILES 93
14.1 JOTEC GMBH (ACQUIRED BY CRYOLIFE, INC.) 93
14.1.1 Key Facts 93
14.1.2 Business Description 93
14.1.3 Financial Information 94
14.1.4 Product Portfolio 94
14.1.5 Key Developments 94
14.2 W. L. GORE & ASSOCIATES. 95
14.2.1 Key Facts 95
14.2.2 Business Description 95
14.2.3 Financial Overview 95
14.2.4 Product Portfolio 95
14.2.5 Key Developments 95
14.3 OPTIMED MEDIZINISCHE INSTRUMENTE GMBH 96
14.3.1 Key Facts 96
14.3.2 Business Description 96
14.3.3 Financial Overview 96
14.3.4 Product Portfolio 96
14.3.5 Key Developments 96
14.4 BOSTON SCIENTIFIC CORPORATION 97
14.4.1 Key Facts 97
14.4.2 Business Description 97
14.4.3 Financial Overview 98
14.4.4 Product Portfolio 98
14.4.5 Key Developments 98
14.5 C. R. BARD, INC. (ACQUIRED BY BD) 99
14.5.1 Key Facts 99
14.5.2 Business Description 99
14.5.3 Financial Information 100
14.5.4 Product Portfolio 100
14.5.5 Key Developments 100
14.6 COOK 101
14.6.1 Key Facts 101
14.6.2 Business Description 101
14.6.3 Financial Overview 101
14.6.4 Product Portfolio 101
14.6.5 Key Developments 102
14.7 MEDTRONIC 103
14.7.1 Key Facts 103
14.7.2 Business Description 103
14.7.3 Financial Overview 104
14.7.4 Product Portfolio 104
14.7.5 Key Developments 104
14.8 MEDICA GERMANY GMBH & CO. KG 105
14.8.1 Key Facts 105
14.8.2 Business Description 105
14.8.3 Financial Overview 105
14.8.4 Product Portfolio 105
14.8.5 Key Developments 105
14.9 CORDIS (ACQUIRED BY CARDINAL HEALTH) 106
14.9.1 Key Facts 106
14.9.2 Business Description 106
14.9.3 Financial Overview 107
14.9.4 Product Portfolio 107
14.9.5 Key Developments 107
15. APPENDIX 108
15.1 ABOUT THE INSIGHT PARTNERS 108
15.2 GLOSSARY OF TERMS 109
15.3 METHODOLOGY 112
15.3.1 Coverage 113
15.3.2 Secondary Research 114
15.3.3 Primary Research 114

LIST OF TABLES

TABLE 1. NORTH AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 48
TABLE 2. NORTH AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 49
TABLE 3. NORTH AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 49
TABLE 4. US VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 51
TABLE 5. US VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 52
TABLE 6. US VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 52
TABLE 7. CANADA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 54
TABLE 8. CANADA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 54
TABLE 9. CANADA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 54
TABLE 10. MEXICO VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 56
TABLE 11. MEXICO VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 56
TABLE 12. MEXICO VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 56
TABLE 13. EUROPE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 58
TABLE 14. EUROPE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 59
TABLE 15. EUROPE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 59
TABLE 16. GERMANY VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 62
TABLE 17. GERMANY VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 62
TABLE 18. GERMANY VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 62
TABLE 19. UK VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 64
TABLE 20. UK VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 64
TABLE 21. UK VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 64
TABLE 22. FRANCE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 66
TABLE 23. FRANCE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 66
TABLE 24. FRANCE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 66
TABLE 25. ASIA PACIFIC VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 68
TABLE 26. ASIA PACIFIC VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 69
TABLE 27. ASIA PACIFIC VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 69
TABLE 28. CHINA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 71
TABLE 29. CHINA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 72
TABLE 30. CHINA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 72
TABLE 31. JAPAN VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 74
TABLE 32. JAPAN VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 74
TABLE 33. JAPAN VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 74
TABLE 34. INDIA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 76
TABLE 35. INDIA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 76
TABLE 36. INDIA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 76
TABLE 37. MIDDLE EAST & AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 78
TABLE 38. MIDDLE EAST & AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 79
TABLE 39. MIDDLE EAST & AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 79
TABLE 40. U.A.E. VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 82
TABLE 41. U.A.E. VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 82
TABLE 42. U.A.E. VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 82
TABLE 43. SAUDI ARABIA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 84
TABLE 44. SAUDI ARABIA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 84
TABLE 45. SAUDI ARABIA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 84
TABLE 46. SOUTH AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 86
TABLE 47. SOUTH AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 86
TABLE 48. SOUTH AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 86
TABLE 49. SOUTH AND CENTRAL AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 88
TABLE 50. SOUTH AND CENTRAL AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 89
TABLE 51. SOUTH AND CENTRAL AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 89
TABLE 52. BRAZIL VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 92
TABLE 53. BRAZIL VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 92
TABLE 54. BRAZIL VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN) 92
TABLE 55. GLOSSARY OF TERMS, VENOUS STENTS 109

LIST OF FIGURES

FIGURE 1. ASIA PACIFIC VENOUS STENTS MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2017 & 2025 20
FIGURE 2. GLOBAL VENOUS STENTS MARKET BY TECHNOLOGY, MARKET SHARE (%), 2017 21
FIGURE 3. GLOBAL VENOUS STENTS MARKET BY APPLICATION, MARKET SHARE (%), 2017 21
FIGURE 4. GLOBAL VENOUS STENTS MARKET BY DISEASE, MARKET SHARE (%), 2017 22
FIGURE 5. VENOUS STENTS MARKET SEGMENTATION 23
FIGURE 6. VENOUS STENTS MARKET SEGMENTATION, BY REGION 24
FIGURE 7. VENOUS STENTS MARKET IMPACT ANALYSIS OF DRIVER AND RESTRAINTS 29
FIGURE 8. GLOBAL VENOUS STENTS – REVENUE FORECASTS AND ANALYSIS – 2016- 2025 30
FIGURE 9. GLOBAL VENOUS STENTS – BY GEOGRAPHY FORECASTS AND ANALYSIS – 2017- 2025 31
FIGURE 10. GLOBAL VENOUS STENTS MARKET, BY TECHNOLOGY 2017 & 2025 (%) 34
FIGURE 11. GLOBAL WALLSTENT TECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 35
FIGURE 12. GLOBAL ILIAC VEIN STENT TECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 36
FIGURE 13. GLOBAL VENOUS STENTS MARKET, BY APPLICATION 2017 & 2025 (%) 37
FIGURE 14. GLOBAL LEGS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 38
FIGURE 15. GLOBAL CHEST MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 39
FIGURE 16. GLOBAL ABDOMEN MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 40
FIGURE 17. GLOBAL VENOUS STENTS MARKET, BY DISEASE 2017 & 2025 (%) 41
FIGURE 18. GLOBAL POST THROMBOTIC SYNDROME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 42
FIGURE 19. GLOBAL CHRONIC DEEP VEIN THROMBOSIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 43
FIGURE 20. GLOBAL MAY-THURNER SYNDROME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 44
FIGURE 21. GLOBAL HEMODIALYSIS/ARTERIOVENOUS FISTULAE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 45
FIGURE 22. GLOBAL OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 46
FIGURE 23. NORTH AMERICA VENOUS STENTS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US$ MN) 47
FIGURE 24. NORTH AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 48
FIGURE 25. NORTH AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY, (2017 & 2025) (%) 50
FIGURE 26. US VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 51
FIGURE 27. CANADA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 53
FIGURE 28. MEXICO VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 55
FIGURE 29. EUROPE VENOUS STENTS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US$ MN) 57
FIGURE 30. EUROPE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 58
FIGURE 31. EUROPE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY, (2017 & 2025) (%) 60
FIGURE 32. GERMANY VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 61
FIGURE 33. UK VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 63
FIGURE 34. FRANCE VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 65
FIGURE 35. ASIA PACIFIC VENOUS STENTS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US$ MN) 67
FIGURE 36. ASIA PACIFIC VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 68
FIGURE 37. ASIA PACIFIC VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY, (2017 & 2025) (%) 70
FIGURE 38. CHINA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 71
FIGURE 39. JAPAN VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 73
FIGURE 40. INDIA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 75
FIGURE 41. MIDDLE EAST & AFRICA VENOUS STENTS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US$ MN) 77
FIGURE 42. MIDDLE EAST & AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 78
FIGURE 43. MIDDLE EAST & AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY, (2017 & 2025) (%) 80
FIGURE 44. U.A.E. VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 81
FIGURE 45. SAUDI ARABIA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 83
FIGURE 46. SOUTH AFRICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 85
FIGURE 47. SOUTH AND CENTRAL AMERICA VENOUS STENTS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US$ MN) 87
FIGURE 48. SOUTH AND CENTRAL AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 88
FIGURE 49. SOUTH & CENTRAL AMERICA VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY, (2017 & 2025) (%) 90
FIGURE 50. BRAZIL VENOUS STENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 91

The List of Companies

  1. Boston Scientific Corporation
  2. C. R Bard (acquired by BD)
  3. Jotech GMBH (acquired by Cryolife, Inc.)
  4. Cook
  5. W.L Gore & Associates
  6. Optimed Medizinische Instrumente GMBH
  7. Medtronic
  8. Medica Germany GMBH & Co. KG
  9. Cordis (acquired by Cardinal Health)
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the orthopedic braces and supports market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global orthopedic braces and supports market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPMD00002388
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.